Favipiravir
- All
- News
- Videos
-
Baby's Dark-Brown Eyes Turn Blue After Covid-19 Treatment In Thailand: Report
- Thursday September 7, 2023
- Science | Edited by Nikhil Pandey
The dark brown eyes of a 6-month-old infant in Thailand temporarily turned indigo blue after receiving a common COVID-19 treatment.
- www.ndtv.com
-
Ivermectin, HCQ Dropped From One Covid Treatment List, Kept On Another
- Monday June 7, 2021
- India News | Reported by Parimal Kumar, Edited by Arun Nair
The Union health ministry has issued revised guidelines for management of Covid-infected patients, dropping many sought-after drugs like ivermectin, hydroxychloroquine and anti-viral Favipiravir from Covid treatment.
- www.ndtv.com
-
Vivimed Labs Gains On Receiving Government's Approval To Make Favipiravir
- Monday May 10, 2021
- Business | Edited by Abhishek Vasudev
Favipiravir is indicated to treat mild to moderate cases of Covid-19 infection and is in short supply owing to rising Covid-19 infections in the country.
- www.ndtv.com/business
-
19 States Mapped With Remdesivir Manufacturers For Faster Supply
- Sunday April 25, 2021
- India News | Reported by Sunil Prabhu, Edited by Debanish Achom
The centre has mapped manufacturers of the anti-viral drug remdesivir with 19 states that have high Covid case burden. This will ensure smooth and fast delivery of the medicine, the centre said in a statement.
- www.ndtv.com
-
COVID-19: Supreme Court Seeks Centre's Reply On Plea Claiming No Approval For Remdesivir
- Thursday October 29, 2020
- India News | Press Trust of India
The Supreme Court today sought the Centre's reply on a plea alleging that two medicines Remdesivir and Favipiravir, are being used for treatment of COVID-19 without approval.
- www.ndtv.com
-
Lupin Launches COVID-19 Drug Favipiravir In India At Rs 49 Per Tablet
- Wednesday August 5, 2020
- India News | Press Trust of India
Drug major Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name "Covihalt" for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India.
- www.ndtv.com
-
Lupin Launches Its Version Of Favipiravir Drug To Treat COVID-19
- Wednesday August 5, 2020
- Business | Edited by Abhik Deb (with inputs from agencies)
Lupin's Covihalt will be available as 200 mg tablets in the form of a strip of 10 tablets, and priced at Rs 49 per tablet
- www.ndtv.com/business
-
Zenara Pharma Receives Nod To Sell Covid-19 Drug Favipiravir
- Wednesday August 5, 2020
- Business | Edited by Peter Noronha
Zenara Pharma: The Hyderabad-based company has received an approval to sell Favipiravir tablets for treating patients with mild to moderate symptoms of Covid-19.
- www.ndtv.com/business
-
Sun Pharma Company Launches COVID-19 Drug Favipiravir In India
- Tuesday August 4, 2020
- India News | ANI
Sun Pharmaceutical Industries has said it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
- www.ndtv.com
-
Cipla Set To Launch Favipiravir Drug For Treatment Of COVID Patients
- Friday July 24, 2020
- India News | Press Trust of India
Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients, according to an official statement on Thursday.
- www.ndtv.com
-
Central Drug Agency Seeks Clarification From Glenmark On Its COVID-19 Drug
- Monday July 20, 2020
- India News | ANI
The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on COVID-19 patients with comorbidities.
- www.ndtv.com
-
No Game Changers: Medical Experts On Remdesiver, Favipiravir For COVID Treatment
- Tuesday June 23, 2020
- India News | Press Trust of India
With pharmaceutical companies launching generic versions of Remdesivir and Favipiravir for COVID-19 treatment, medical experts on Monday said it was a "positive development" in the fight against the pandemic, but cautioned against regarding the antiviral drugs as "game changers".
- www.ndtv.com
-
Baby's Dark-Brown Eyes Turn Blue After Covid-19 Treatment In Thailand: Report
- Thursday September 7, 2023
- Science | Edited by Nikhil Pandey
The dark brown eyes of a 6-month-old infant in Thailand temporarily turned indigo blue after receiving a common COVID-19 treatment.
- www.ndtv.com
-
Ivermectin, HCQ Dropped From One Covid Treatment List, Kept On Another
- Monday June 7, 2021
- India News | Reported by Parimal Kumar, Edited by Arun Nair
The Union health ministry has issued revised guidelines for management of Covid-infected patients, dropping many sought-after drugs like ivermectin, hydroxychloroquine and anti-viral Favipiravir from Covid treatment.
- www.ndtv.com
-
Vivimed Labs Gains On Receiving Government's Approval To Make Favipiravir
- Monday May 10, 2021
- Business | Edited by Abhishek Vasudev
Favipiravir is indicated to treat mild to moderate cases of Covid-19 infection and is in short supply owing to rising Covid-19 infections in the country.
- www.ndtv.com/business
-
19 States Mapped With Remdesivir Manufacturers For Faster Supply
- Sunday April 25, 2021
- India News | Reported by Sunil Prabhu, Edited by Debanish Achom
The centre has mapped manufacturers of the anti-viral drug remdesivir with 19 states that have high Covid case burden. This will ensure smooth and fast delivery of the medicine, the centre said in a statement.
- www.ndtv.com
-
COVID-19: Supreme Court Seeks Centre's Reply On Plea Claiming No Approval For Remdesivir
- Thursday October 29, 2020
- India News | Press Trust of India
The Supreme Court today sought the Centre's reply on a plea alleging that two medicines Remdesivir and Favipiravir, are being used for treatment of COVID-19 without approval.
- www.ndtv.com
-
Lupin Launches COVID-19 Drug Favipiravir In India At Rs 49 Per Tablet
- Wednesday August 5, 2020
- India News | Press Trust of India
Drug major Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name "Covihalt" for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India.
- www.ndtv.com
-
Lupin Launches Its Version Of Favipiravir Drug To Treat COVID-19
- Wednesday August 5, 2020
- Business | Edited by Abhik Deb (with inputs from agencies)
Lupin's Covihalt will be available as 200 mg tablets in the form of a strip of 10 tablets, and priced at Rs 49 per tablet
- www.ndtv.com/business
-
Zenara Pharma Receives Nod To Sell Covid-19 Drug Favipiravir
- Wednesday August 5, 2020
- Business | Edited by Peter Noronha
Zenara Pharma: The Hyderabad-based company has received an approval to sell Favipiravir tablets for treating patients with mild to moderate symptoms of Covid-19.
- www.ndtv.com/business
-
Sun Pharma Company Launches COVID-19 Drug Favipiravir In India
- Tuesday August 4, 2020
- India News | ANI
Sun Pharmaceutical Industries has said it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
- www.ndtv.com
-
Cipla Set To Launch Favipiravir Drug For Treatment Of COVID Patients
- Friday July 24, 2020
- India News | Press Trust of India
Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients, according to an official statement on Thursday.
- www.ndtv.com
-
Central Drug Agency Seeks Clarification From Glenmark On Its COVID-19 Drug
- Monday July 20, 2020
- India News | ANI
The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on COVID-19 patients with comorbidities.
- www.ndtv.com
-
No Game Changers: Medical Experts On Remdesiver, Favipiravir For COVID Treatment
- Tuesday June 23, 2020
- India News | Press Trust of India
With pharmaceutical companies launching generic versions of Remdesivir and Favipiravir for COVID-19 treatment, medical experts on Monday said it was a "positive development" in the fight against the pandemic, but cautioned against regarding the antiviral drugs as "game changers".
- www.ndtv.com